Your session is about to expire
← Back to Search
This trial will study if ozanimod is effective, safe, and has desired drug levels and effects in children with Crohn's Disease.
Inclusion CriteriaYou will be eligible if you check “Yes” for the criteria below
Study ObjectivesOutcome measures can provide a clearer picture of what you can expect from a treatment.
Side effects dataFrom 2017 Phase 3 trial • 1320 Patients • NCT02047734
Awards & Highlights
Find a Location
Who is running the clinical trial?
- There are additional requirements for participation that are specific to this study.You have tried and failed to get better with different types of medication for Crohn's Disease, including steroids, immunomodulators, biologics or other therapies.The doctor thinks you may need to have surgery on your bowel within 12 weeks of starting the study.
- Group 1: Ozanimod Dose Level 1
- Group 2: Ozanimod Dose Level 2
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Does this research include middle-aged or older individuals?
"This clinical trial requires participants to be between 2 and 17 years old."
Are there any current openings for patients who wish to participate in this research?
"The clinical trial in question is not presently recruiting patients, as indicated by information found on clinicaltrials.gov. This study was first posted on October 27th, 2022 and last updated on November 4th, 2022. There are 258 other trials that are actively looking for participants."
Are there specific eligibility requirements for participants in this research?
"Eligibility criteria for this study includes having ileocolitis and being between the ages of 2-17. The trial plans to enroll around 120 patients in total."
Are there a great deal of sites running this experiment in the city?
"Currently, University of Iowa Stead Family Children's Hospital in Iowa City, Valley Medical Group (VMG) - Pediatric Gastroenterology in Paramus, and Children's Hospital Coloradof Iowa Stead Family Children's Hospital in Iowa City, Valley Medical Group (VMG) - Pediatric Gastroenterology in Paramus, and Children's Hospital Colorado in Aurora are enrolling patients for this clinical trial. There are also 7 other locations where this study is being conducted."
Share this study with friends